Clinical applicability
Betahistine is one of the most used empirical treatments, requiring a
better scientific approach. To the best of our knowledge, this
randomized clinical trial is the first reliable study to test this
treatment for this purpose. Our results reveal that this drug is
ineffective for primary tinnitus in adults, therefore, its large-scale
use is likely to be of no benefit to patients. We believe that this
result can avoid the negative impact of the use of ineffective
treatments by these patients.